Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Bayer
The study has previously been posted by Schering AG, Germany. Schering AG, Germany has been renamed to Bayer Schering Pharma AG, Germany.Bayer Schering Pharma AG, Germany is the sponsor of the trial.
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Non small cell lung cancer, Stage IIIB or Stage IV
One and only 1 prior platinum-based chemotherapy
No other uncontrolled concurrent illness
Use of highly effective birth control methods in males or females with reproductive potential
You may not be if
Previous participation in another trial within the last 4 weeks
Surgery within 10 days prior to the start of study treatment
Brain metastases
Confirmed diagnosis of infection with the human immunodeficiency virus (HIV)
Current treatment with warfarin sodium (Coumadin) or similar anticoagulation medication
Breast feeding
Clareo Health | Safety and Efficacy Study of a New Chemotherapy Agent to Treat Non Small Cell Lung Cancer.
